Cathie Wood Bets Big on SpaceX Even as Elon Musk Warns Short Sellers — Ark Keeps Dumping Robinhood Sharesbenzinga_article·23 hours agoPRME-3.88%HOOD-2.78%
Prime Medicine (NASDAQ:PRME) Shares Down 6.5% - Should You Sell?Market Beat·Jul 13 at 12:00 PMPRME-3.88%
LifeSci Capital Remains a Buy on Prime Medicine, Inc. (PRME)Tip Ranks·Jul 11 at 09:35 AMPRME-3.88%RANK-0.72%
Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal BattleUnusual Whales·Jul 8 at 01:27 PMBEAM-2.74%PRME-3.88%
Prime Medicine posts corporate deck highlighting prime-editing platform, lead programs in Wilson disease and AATDPUBT·Jul 8 at 07:22 AMPRME-3.88%
Prime Medicine wins arbitration with Beam over AATD therapy PM647PUBT·Jul 8 at 07:04 AMPRME-3.88%BEAM-2.74%
This Caseys Analyst Turns Bullish; Here Are Top 3 Upgrades For Mondaybenzinga_article·Jun 29 at 07:42 AMCASY+2.16%PRME-3.88%
Prime Medicine says New Zealand clears clinical trial application for Wilson disease therapy PM577aPUBT·Jun 18 at 07:03 AMPRME-3.88%
Is Prime Medicine (NASDAQ:PRME) In A Good Position To Invest In Growth?Simplywall·Jun 18 at 05:59 AMPRME-3.88%
JonesTrading Reaffirms Their Buy Rating on Prime Medicine, Inc. (PRME)Tip Ranks·May 8 at 02:16 PMPRME-3.88%XBI+8.00%
